Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system

Osteosarcoma is the most common type primary malignant tumor of bone. Patients with regional osteosarcoma are routinely treated with surgery and chemotherapy. In addition, many patients with metastatic or recurrent osteosarcoma show poor prognosis with current chemotherapy agents. Therefore, it is i...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Orthop Res
Huvudupphovsmän: Feng, Yong, Sassi, Slim, Shen, Jacson K, Yang, Xiaoqian, Gao, Yan, Osaka, Eiji, Zhang, Jianming, Yang, Shuhua, Yang, Cao, Mankin, Henry J., Hornicek, Francis J, Duan, Zhenfeng
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2014
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4304907/
https://ncbi.nlm.nih.gov/pubmed/25348612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jor.22745
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk